Miguel Ángel H. P.
- Country
- Spain
- Department
- Neurology
Research Overview
- Evaluation of Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Versus Intravenous Ocrelizumab in Multiple Sclerosis Patients
- Evaluation of Amantadine Hydrochloride and Transcranial Magnetic Stimulation for Fatigue Management in Multiple Sclerosis: A Phase III Randomized Controlled Trial
Data & Insights
Has run more than one trial at 0 of 21 partner sites.
Specializations
Multiple Sclerosis Treatment
The investigator specializes in innovative therapeutic approaches for multiple sclerosis (MS), with particular emphasis on managing MS-related symptoms and exploring novel treatment delivery methods.
- Fatigue Management in MS
- Combination Therapy Approaches
- Drug Administration Methods
Their research encompasses both traditional pharmaceutical interventions and advanced therapeutic techniques such as transcranial magnetic stimulation.
Neurological Therapeutics
The investigator focuses on developing and evaluating treatment administration routes for neurological conditions, particularly comparing subcutaneous and intravenous delivery systems.
- Drug Delivery Systems
- Pharmacokinetic Studies
- Clinical Effects Assessment
Their work includes comprehensive evaluation of pharmacodynamics and safety profiles in neurological treatments.
Clinical Assessment Methods
The investigator employs advanced methodologies for evaluating therapeutic outcomes in neurological conditions, incorporating radiological assessment techniques.
- Treatment Efficacy Measures
- Therapeutic Response Monitoring
- Clinical Outcomes Assessment
Their research includes the use of specialized scales such as the MFIS scale for measuring treatment effects.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.